Do you want to read an article? Please log in or register.
Pre-diagnostic Plasma Metabolite Profiles and Prediction of Hepatocellular Carcinoma Risk: the Multiethnic Cohort
Gastrointestinal Cancer
Related content
Gastrointestinal CancerHepatology
Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma
J Hepatol
Yopp A, Chen M, Cheng AL, Kaseb A, Kudo M, Lee HC, Cha E, Hack SP, Lian Q, Spahn J, Wu C, Qin S, Chow PK
doi: 10.1016/j.jhep.2026.01.006
Inflammatory Bowel Disease
Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn's Disease and Ulcerative Colitis
Inflamm Bowel Dis
Gan X, Zhang Y, Zhang Y, Ye Z, Yang S, Xiang H, Huang Y, Wu Y, Zhang Y, Qin X
doi: 10.1093/ibd/izaf325
RECOMMENDED
Inflammatory Bowel Disease
Prediction of inflammatory bowel disease based on early life risk factors in a population-based cohort
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol
Agrawal M, Hansen AV, Julsgaard M, Colombel JF, Jess T
doi: 10.1016/j.cgh.2026.01.034
Gastrointestinal Cancer
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort
J Clin Oncol
Moon AM, Yanagihara TK, Dawson LA, Yu JI, Lawrence TS, Kim TH, Yan M, Iwata H, Nabavizadeh N, Apisarnthanarax S, Dunne EM, Lock MI, Chuong MD, Chiang CL, Scorsetti M, Katoh N, Sioshansi S, Numata K, Liu HY, Iwamoto H, Wakatsuki M, Chen Y, Pollom EL, Gkika E, Jabbour SK, Munoz-Schuffenegger P, Dutta D, Hajj C, Ueno M, Hallemeier CL, Feldman AM, Méndèz Romero A, Tan X, Molla M, Tepper JE, Torres F, Reig M, EBRT Collaboration Group
doi: 10.1200/JCO-25-02399
HepatitisHepatology
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease
Gut
Chang YP, Chen YC, Cheng PN, Fang YJ, Chen CY, Kao WY, Lin CL, Yang SS, Shih YL, Peng CY, Lee FJ, Tsai MC, Huang SC, Su TH, Tseng TC, Liu CJ, Chen PJ, Kao JH, Liu CH
doi: 10.1136/gutjnl-2025-337275
Hepatology
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
Hepatology
Nahon P, Ziol M, Pan L, Portal JJ, Oberti F, Aube C, Blanc JF, Trillaud H, Merle P, Rode A, Assenat E, Guiu B, Lequoy M, Cornelis F, Bouattour M, Talib Z, Tibi A, Zeng Q, Bouda Y, Ganne-Carrié N, Sutter O, Sutton A, Guyot E, Barget N, Zucman-Rossi J, Campani C, Bamba-Funck J, Calderaro J, Nault JC, Vicaut E, Seror O
doi: 10.1097/HEP.0000000000001764
HepatitisHepatology
Validation of THCC-RI in the Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study
Clin Gastroenterol Hepatol
Kanwal F, Lopez C, Ning J, Luster M, Reddy KR, Parikh ND, Singal AG, Marrero JA, Chhatwal J, Feng Z, Page-Lester S, Koay EJ, El-Serag HB
doi: 10.1016/j.cgh.2026.01.041
Gastrointestinal Cancer
Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study
J Hepatocell Carcinoma
von Schoen-Angerer G, Pesola G, Garo ML, Marini G, Cappio S, Cerny A, Magenta L, Majno-Hurst P, Bernardi L, Cefalì M, Cristaudi A, Terziroli Beretta-Piccoli B, Trevisi E, De Dosso S
doi: 10.2147/JHC.S598858
Gastrointestinal Cancer
Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma
Eur J Cancer
Chen X, Sun S, Li S, Yu S, Chen J, Chen X, Shi X, Liang Z
doi: 10.1016/j.ejca.2025.116159